Soligenix
SNGX
#10569
Rank
S$7.38 M
Marketcap
S$0.50
Share price
0.57%
Change (1 day)
-79.45%
Change (1 year)

Earnings for Soligenix (SNGX)

Earnings in 2025 (TTM): -S$16.34 Million

According to Soligenix's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -S$11.94 Million a decrease over its 2023 earnings that were of -S$9.71 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Soligenix from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$16.34 Million36.83%
2024 -S$11.94 Million22.96%
2023 -S$9.71 Million-45.74%
2022 -S$17.9 Million11.88%
2021 -S$16 Million-32.37%
2020 -S$23.65 Million83.18%
2019 -S$12.91 Million11.57%
2018 -S$11.58 Million19.29%
2017 -S$9.7 Million33%
2016 -S$7.3 Million-19.7%
2015 -S$9.09 Million5.16%
2014 -S$8.64 Million
2010 -S$9.75 Million26.12%
2009 -S$7.73 Million75.1%
2008 -S$4.42 Million-45.38%
2007 -S$8.09 Million-22.84%
2006 -S$10.48 Million66.15%
2005 -S$6.31 Million-16.65%
2004 -S$7.57 Million13.28%
2003 -S$6.68 Million-11.88%
2002 -S$7.58 Million-59.44%
2001 -S$18.68 Million378.18%
2000 -S$3.91 Million-38.53%
1999 -S$6.36 Million-18.43%
1998 -S$7.8 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$33.18 B-210,134.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$13.52 B-85,726.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$9.78 B-62,017.23%๐Ÿ‡ซ๐Ÿ‡ท France
Onconova Therapeutics
ONTX
-S$23.19 Million 46.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-S$53.34 Million 237.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$2.90 B-18,460.57%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Cleveland BioLabs
CBLI
-S$3.52 Million-77.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
S$0.21 B-1,436.42%๐Ÿ‡บ๐Ÿ‡ธ USA